Pharma & Biotech
BioPorto places focus on flagship NGAL kidney-injury test
Biocept changing the way physicians examine blood work for their cancer patients
Kazia Therapeutics studies evaluate therapeutic candidates in ovarian cancer and brain tumours
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.